Nathan Hale Fowler

23PUBLICATIONS
122CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Psychology of ageing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Mar 26, 2026
Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid Tumors.

Burak Uzunparmak, Fei Su, Amber Johnson

|Jul 19, 2024
Correction to: Moving T‑Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review.

Nathan Hale Fowler, Julio C Chavez, Peter A Riedell

|Jun 19, 2024
Moving T-Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review.

Nathan Hale Fowler, Julio C Chavez, Peter A Riedell

|Mar 30, 2024
Procrustes is a machine-learning approach that removes cross-platform batch effects from clinical RNA sequencing data.

Nikita Kotlov, Kirill Shaposhnikov, Cagdas Tazearslan

|Feb 08, 2024
Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphoma.

Sravya Tumuluru, James K Godfrey, Alan Cooper

|Jan 09, 2024
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update.

Martin Dreyling, Nathan Hale Fowler, Michael Dickinson

Pageof 4

Frequent Collaborators

5 joint publications

Chelsea C Pinnix

4 joint publications

Loretta Nastoupil

4 joint publications

Jason Westin

4 joint publications

Raphael Steiner